Machine learning to predict post-therapy dosimetry for 177Lu-PSMA I&T treatment

被引：0
作者：
Shi, K. [1 ]
Xue, S. [1 ]
Gafita, A. [2 ]
Dong, C. [2 ]
Zhao, Y. [2 ]
Tetteh, G. [2 ]
Menze, B. H. [2 ]
Afshar-Oromieh, A. [1 ]
Eiber, M. [2 ]
Rominger, A. [1 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Tech Univ Munich, Munich, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-441
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
[21]   Quantitative imaging for 177Lu-PSMA treatment response monitoring and dosimetry [J].
Meyer, Catherine ;
Szidonya, Laszlo ;
Winters, Celeste ;
Mench, Anna ;
Mallak, Nadine ;
Mittra, Erik .
FRONTIERS IN NUCLEAR MEDICINE, 2023, 3
[22]   Radiation dosimetry for 177Lu-PSMA I&T therapy in metastatic prostate cancer: results for normal organs, tumor lesions and comparison between different cycles [J].
Okamoto, Shozo ;
Thieme, Anne ;
Allmann, Jakob ;
Maurer, Tobias ;
Retz, Margitta ;
Tauber, Robert ;
Heck, Matthias ;
Wester, Hans-Juergen ;
Tamaki, Nagara ;
Scheidhauer, Klemens ;
Schwaiger, Markus ;
Ziegler, Sibylle ;
Eiber, Matthias .
JOURNAL OF NUCLEAR MEDICINE, 2016, 57
[23]   Value of post-therapy 177Lu-PSMA images for accurate interpretation of therapy response with 68Ga-PSMA PET/CT [J].
Tuncel, M. ;
Telli, T. .
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02) :114-117
[24]   Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry [J].
Schuchardt, Christiane ;
Zhang, Jingjing ;
Kulkarni, Harshad R. ;
Chen, Xiaoyuan ;
Mueller, Dirk ;
Baum, Richard P. .
JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (08) :1199-1207
[25]   Improved quality control of [177Lu]Lu-PSMA I&T [J].
Kraihammer, Martin ;
Garnuszek, Piotr ;
Bauman, Andreas ;
Maurin, Michael ;
Lafont, Manuel Alejandre ;
Haubner, Roland ;
von Guggenberg, Elisabeth ;
Gabriel, Michael ;
Decristoforo, Clemens .
EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
[26]   Improved quality control of [177Lu]Lu-PSMA I&T [J].
Martin Kraihammer ;
Piotr Garnuszek ;
Andreas Bauman ;
Michael Maurin ;
Manuel Alejandre Lafont ;
Roland Haubner ;
Elisabeth von Guggenberg ;
Michael Gabriel ;
Clemens Decristoforo .
EJNMMI Radiopharmacy and Chemistry, 8
[27]   Organ-regularized Deep Learning for Voxel-wise Prediction of Post-therapy Dosimetry for 177Lu PSMA Therapy [J].
Xue, Song ;
Gafita, Andrei ;
Afshar-Oromieh, Ali ;
Eiber, Matthias ;
Rominger, Axel ;
Shi, Kuangyu .
JOURNAL OF NUCLEAR MEDICINE, 2023, 64
[28]   Lu-177 PSMA I&T Therapy for Prostate Cancer; Treatment Response, Treatment Toxicity, and Survival Results [J].
Acar, Emine ;
Sonmezer, Burak ;
Derebek, Erkan ;
Bekis, Recep ;
Ozdogan, Ozhan ;
Kaya, Gamze Capa .
JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2019, 3 (03) :158-164
[29]   Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions [J].
Okamoto, Shozo ;
Thieme, Anne ;
Allmann, Jakob ;
D'Alessandria, Calogero ;
Maurer, Tobias ;
Retz, Margitta ;
Tauber, Robert ;
Heck, Matthias M. ;
Wester, Hans-Juergen ;
Tamaki, Nagara ;
Fendler, Wolfgang P. ;
Herrmann, Ken ;
Pfob, Christian H. ;
Scheidhauer, Klemens ;
Schwaiger, Markus ;
Ziegler, Sibylle ;
Eiber, Matthias .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) :445-450
[30]   Optimising the Synthesis and QC of [177Lu]Lu-PSMA I&T for Prostate Cancer Therapy [J].
Hong, K. ;
Fincher, L. ;
Browne, E. .
INTERNAL MEDICINE JOURNAL, 2022, 52 :53-54
12345